Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Colorectal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00900432
What this trial is testing

Immune Response in Peripheral Blood of Patients With Colon Cancer

Who this might be right for
Colorectal Cancer
University of Arizona 67
Early research (Phase 1)Study completedNCT00019006
What this trial is testing

Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer

Who this might be right for
Recurrent Colon CancerExtensive Stage Small Cell Lung CancerStage III Pancreatic Cancer+11 more
National Cancer Institute (NCI)
Not applicableUnknownNCT03700593
What this trial is testing

Feasibility and Safety of Single Port Robot in Colorectal Procedures

Who this might be right for
Colon CancerColon PolypRectal Cancer+4 more
Marks Colorectal Surgical Associates 200
Large-scale testing (Phase 3)Looking for participantsNCT06490536
What this trial is testing

The Sagittarius Trial

Who this might be right for
Colon Cancer Stage IIColon Cancer Stage III
IFOM ETS - The AIRC Institute of Molecular Oncology 700
Early research (Phase 1)Study completedNCT03689192
What this trial is testing

Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors

Who this might be right for
Non Small Cell Lung CancerUrothelial CarcinomaMalignant Melanoma+5 more
Herlev Hospital 13
Testing effectiveness (Phase 2)UnknownNCT01929499
What this trial is testing

Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer

Who this might be right for
Colonic Neoplasms
Yanjuan Zhu 210
Testing effectiveness (Phase 2)UnknownNCT06436976
What this trial is testing

The Effect of Probiotics ATG-F4 in Cancer Patients

Who this might be right for
Pancreatic CancerColon Cancer
Chungnam National University Hospital 30
Not applicableStudy completedNCT01639443
What this trial is testing

Reducing VA No-Shows: Evaluation of Predictive Overbooking Applied to Colonoscopy

Who this might be right for
Colon Cancer
VA Office of Research and Development 180
Not applicableLooking for participantsNCT07098182
What this trial is testing

Contribution of Preserving the Superior Left Colic Artery to the Vascularization of the Descending Colon Prior to Colorectal Anastomosis During Left-Sided or Rectal Resections for Colorectal or Ovarian Cancer. (Revascularisation Colique)

Who this might be right for
Rectal CancerColon CancerOvarian Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 50
Not applicableNot Yet RecruitingNCT06067620
What this trial is testing

Robotic Right Hemicolectomy Versus Laparoscopic Right Hemicolectomy

Who this might be right for
Colorectal NeoplasmsColorectal Neoplasms MalignantColorectal Neoplasms, Benign+4 more
Jeremy Meyer 70
Large-scale testing (Phase 3)UnknownNCT00797485
What this trial is testing

Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Southern Italy Cooperative Oncology Group 672
Not applicableEnded earlyNCT07350590
What this trial is testing

Comparison Between Robotic and Laparoscopic Right Hemicolectomy

Who this might be right for
Right-sided Colon Cancer
Sir Run Run Shaw Hospital 771
Testing effectiveness (Phase 2)Ended earlyNCT00397878
What this trial is testing

AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+3 more
National Cancer Institute (NCI) 10
Large-scale testing (Phase 3)Study completedNCT00002968
What this trial is testing

Edrecolomab in Treating Patients With Stage II Colon Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonSignet Ring Adenocarcinoma of the ColonStage IIA Colon Cancer+2 more
National Cancer Institute (NCI) 2,100
Large-scale testing (Phase 3)Study completedNCT00112918
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 3,451
Testing effectiveness (Phase 2)Ended earlyNCT00107315
What this trial is testing

Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Roswell Park Cancer Institute 16
Not applicableTemporarily pausedNCT04955808
What this trial is testing

Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery

Who this might be right for
Breast CarcinomaColon CarcinomaInvasive Carcinoma+5 more
National Cancer Institute (NCI) 2,400
Not applicableEnded earlyNCT01163526
What this trial is testing

Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies

Who this might be right for
Neuroendocrine TumorsBrain (Nervous System) CancersColon/Rectal Cancer+4 more
Stanford University 13
Not applicableUnknownNCT05362825
What this trial is testing

Surgery Outcome Treated by Neo-adjuvant Combination of Oxaliplatin, Irinotecan, Folinic Acid and Fluorouracil (FOLFOXIRI) Regimen in Synchronous Liver Limited Metastasis Colorectal Cancer

Who this might be right for
Liver Metastasis Colon CancerSynchronous Neoplasm
Cho Ray Hospital 89
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Next Page